Use of Melatonin in Oxidative Stress Related Neonatal Diseases

Gabriella D'Angelo1, Roberto Chimenz2, Russel J Reiter3

  • 1Neonatal and Pediatric Intensive Care Unit, Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi", University of Messina, 98125 Messina, Italy.

Insights

Melatonin may help prevent or reduce oxidative stress-related diseases in newborns. This antioxidant is being studied for its potential to protect preterm infants from conditions like brain injury, sepsis, chronic lung disease, and necrotizing enterocolitis.

Area of Science:

  • Neonatal Medicine
  • Biochemistry
  • Pharmacology

Background:

  • Reactive oxygen species (ROS) are key in perinatal disease pathogenesis.
  • Preterm infants face increased oxidative stress due to inflammation, infections, and high oxygen, compounded by high iron levels and weak antioxidant defenses.
  • Newborns' vulnerability to oxidative stress suggests melatonin's prophylactic potential.

Purpose of the Study:

  • To evaluate melatonin's role in preventing or mitigating oxidative stress-mediated diseases in newborns.
  • To explore melatonin's effectiveness against specific "oxygen radical diseases of the newborn".

Main Methods:

  • Review of existing investigations on melatonin's efficacy.
  • Assessment of melatonin's properties as a free radical scavenger and its diffusion capabilities.

Main Results:

  • Melatonin is an effective direct free-radical scavenger with excellent membrane permeability.
  • Multiple studies indicate melatonin's potential in reducing perinatal brain injury, sepsis, chronic lung disease (CLD), and necrotizing enterocolitis (NEC).

Conclusions:

  • Melatonin's properties support its prophylactic use in newborns to combat oxidative stress.
  • Further research is needed to confirm melatonin's benefits during the perinatal period.